
Biotech & Health
Science Raises $400M for PRIMA Retinal Implant
Science Corporation has raised $400 million in Series D funding to expand access to its PRIMA retinal implant in Europe and prepare for a potential U.S. launch. The financing will also support manufacturing and separate neural-interface research. U.S…